Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
National HealthCare Co. stock logo
NHC
National HealthCare
$104.72
+0.7%
$96.22
$89.14
$138.49
$1.62B0.5155,587 shs27,541 shs
Progyny, Inc. stock logo
PGNY
Progyny
$21.34
+0.4%
$22.10
$13.39
$30.42
$1.83B1.371.71 million shs1.07 million shs
Sharecare, Inc. stock logo
SHCR
Sharecare
$1.43
$1.43
$0.48
$1.44
$531.79M0.512.55 million shsN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$69.98
-0.1%
$83.05
$19.54
$117.75
$2.00B1.96768,760 shs381,141 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
National HealthCare Co. stock logo
NHC
National HealthCare
-0.47%+0.66%+8.46%+11.39%+1.41%
Progyny, Inc. stock logo
PGNY
Progyny
+3.21%+0.28%-6.59%-7.12%-20.32%
Sharecare, Inc. stock logo
SHCR
Sharecare
0.00%0.00%0.00%0.00%+63.71%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
+0.04%+3.30%-37.75%-30.67%+241.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
1.1703 of 5 stars
1.22.00.00.03.61.71.3
Sharecare, Inc. stock logo
SHCR
Sharecare
N/AN/AN/AN/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
3.6237 of 5 stars
2.43.00.00.04.25.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
Progyny, Inc. stock logo
PGNY
Progyny
2.42
Hold$23.459.91% Upside
Sharecare, Inc. stock logo
SHCR
Sharecare
2.00
Hold$1.43N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.75
Moderate Buy$86.7523.96% Upside

Current Analyst Ratings Breakdown

Latest SHCR, WGS, PGNY, and NHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$88.00
5/12/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$23.00 ➝ $21.00
5/9/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$80.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$135.00 ➝ $110.00
5/1/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$105.00 ➝ $78.00
3/31/2025
Progyny, Inc. stock logo
PGNY
Progyny
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$28.00
2/28/2025
Progyny, Inc. stock logo
PGNY
Progyny
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$17.00 ➝ $23.00
(Data available from 5/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
National HealthCare Co. stock logo
NHC
National HealthCare
$1.37B1.18$6.68 per share15.68$59.41 per share1.76
Progyny, Inc. stock logo
PGNY
Progyny
$1.21B1.51$0.60 per share35.58$5.77 per share3.70
Sharecare, Inc. stock logo
SHCR
Sharecare
$445.25M1.19N/AN/A$1.22 per share1.17
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$330.14M6.05N/AN/A$8.78 per share7.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.9213.12N/A10.03%6.87%4.68%N/A
Progyny, Inc. stock logo
PGNY
Progyny
$62.04M$0.5736.7932.832.395.03%11.36%7.87%8/5/2025 (Estimated)
Sharecare, Inc. stock logo
SHCR
Sharecare
-$128.50M-$0.39N/AN/AN/A-33.64%-22.81%-15.96%N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$175.77M-$1.41N/A33.48N/A-17.12%3.33%1.69%7/29/2025 (Estimated)

Latest SHCR, WGS, PGNY, and NHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Progyny, Inc. stock logo
PGNY
Progyny
$0.45$0.17-$0.28$0.17$307.86 million$324.04 million
4/30/2025Q1 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
National HealthCare Co. stock logo
NHC
National HealthCare
$2.562.44%+4.68%36.99%10 Years
Progyny, Inc. stock logo
PGNY
Progyny
N/AN/AN/AN/AN/A
Sharecare, Inc. stock logo
SHCR
Sharecare
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A

Latest SHCR, WGS, PGNY, and NHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.642.7%6/30/20256/30/20258/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
Progyny, Inc. stock logo
PGNY
Progyny
N/A
2.62
2.62
Sharecare, Inc. stock logo
SHCR
Sharecare
N/A
2.02
2.02
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.25
2.40
2.27

Institutional Ownership

CompanyInstitutional Ownership
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
Progyny, Inc. stock logo
PGNY
Progyny
94.93%
Sharecare, Inc. stock logo
SHCR
Sharecare
35.08%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
National HealthCare Co. stock logo
NHC
National HealthCare
14.97%
Progyny, Inc. stock logo
PGNY
Progyny
9.40%
Sharecare, Inc. stock logo
SHCR
Sharecare
30.61%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.46 million13.32 millionN/A
Progyny, Inc. stock logo
PGNY
Progyny
31085.72 million74.68 millionOptionable
Sharecare, Inc. stock logo
SHCR
Sharecare
3,352371.88 million258.05 millionOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,20028.53 million19.97 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

National HealthCare stock logo

National HealthCare NYSE:NHC

$104.72 +0.76 (+0.73%)
As of 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Progyny stock logo

Progyny NASDAQ:PGNY

$21.34 +0.09 (+0.42%)
Closing price 04:00 PM Eastern
Extended Trading
$21.34 0.00 (0.00%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Sharecare stock logo

Sharecare NASDAQ:SHCR

Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.

GeneDx stock logo

GeneDx NASDAQ:WGS

$69.98 -0.04 (-0.06%)
Closing price 04:00 PM Eastern
Extended Trading
$69.26 -0.72 (-1.03%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.